DK0619735T3 - Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion) - Google Patents
Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion)Info
- Publication number
- DK0619735T3 DK0619735T3 DK92921457T DK92921457T DK0619735T3 DK 0619735 T3 DK0619735 T3 DK 0619735T3 DK 92921457 T DK92921457 T DK 92921457T DK 92921457 T DK92921457 T DK 92921457T DK 0619735 T3 DK0619735 T3 DK 0619735T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethanedijyl
- bis
- methyl
- preparation containing
- icrf
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- CYJAWBVQRMVFEO-UHFFFAOYSA-N piperazine-2,6-dione Chemical compound O=C1CNCC(=O)N1 CYJAWBVQRMVFEO-UHFFFAOYSA-N 0.000 title 1
- BMKDZUISNHGIBY-ZETCQYMHSA-N (+)-dexrazoxane Chemical compound C([C@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 BMKDZUISNHGIBY-ZETCQYMHSA-N 0.000 abstract 3
- 238000001035 drying Methods 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 230000002939 deleterious effect Effects 0.000 abstract 1
- 238000012792 lyophilization process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122720A GB9122720D0 (en) | 1991-10-25 | 1991-10-25 | (s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)formulations and their preparation |
| PCT/EP1992/002400 WO1993007873A1 (en) | 1991-10-25 | 1992-10-22 | Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0619735T3 true DK0619735T3 (da) | 2000-12-04 |
Family
ID=10703550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92921457T DK0619735T3 (da) | 1991-10-25 | 1992-10-22 | Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion) |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0619735B1 (da) |
| AT (1) | ATE193205T1 (da) |
| AU (1) | AU2791292A (da) |
| DE (1) | DE69231098T2 (da) |
| DK (1) | DK0619735T3 (da) |
| ES (1) | ES2145748T3 (da) |
| GB (1) | GB9122720D0 (da) |
| GR (1) | GR3034135T3 (da) |
| MX (1) | MX9206139A (da) |
| PT (1) | PT101007B (da) |
| WO (1) | WO1993007873A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265385B1 (en) * | 1996-01-11 | 2001-07-24 | Topo Target Aps | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
| BR0009473A (pt) * | 1999-03-12 | 2001-11-27 | Antianthra Aps | Tratamento de extravasamento acidental deantraciclinas |
| WO2007062076A2 (en) * | 2005-11-23 | 2007-05-31 | Novartis Ag | Dexrazoxane formulations and methods |
| CN114306251B (zh) * | 2021-12-22 | 2023-08-11 | 乐普药业股份有限公司 | 一种含有右雷佐生的冻干制剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1234935A (en) * | 1967-07-03 | 1971-06-09 | Nat Res Dev | Piperazine derivatives |
| US4963551A (en) * | 1987-12-21 | 1990-10-16 | Erbamont Inc. | Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof |
-
1991
- 1991-10-25 GB GB919122720A patent/GB9122720D0/en active Pending
-
1992
- 1992-10-22 ES ES92921457T patent/ES2145748T3/es not_active Expired - Lifetime
- 1992-10-22 AT AT92921457T patent/ATE193205T1/de active
- 1992-10-22 AU AU27912/92A patent/AU2791292A/en not_active Abandoned
- 1992-10-22 DE DE69231098T patent/DE69231098T2/de not_active Expired - Lifetime
- 1992-10-22 DK DK92921457T patent/DK0619735T3/da active
- 1992-10-22 EP EP92921457A patent/EP0619735B1/en not_active Expired - Lifetime
- 1992-10-22 WO PCT/EP1992/002400 patent/WO1993007873A1/en not_active Ceased
- 1992-10-23 MX MX9206139A patent/MX9206139A/es unknown
- 1992-10-23 PT PT101007A patent/PT101007B/pt not_active IP Right Cessation
-
2000
- 2000-08-07 GR GR20000401830T patent/GR3034135T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0619735B1 (en) | 2000-05-24 |
| GB9122720D0 (en) | 1991-12-11 |
| DE69231098D1 (de) | 2000-06-29 |
| DE69231098T2 (de) | 2000-09-14 |
| PT101007A (pt) | 1994-01-31 |
| WO1993007873A1 (en) | 1993-04-29 |
| ATE193205T1 (de) | 2000-06-15 |
| ES2145748T3 (es) | 2000-07-16 |
| AU2791292A (en) | 1993-05-21 |
| EP0619735A1 (en) | 1994-10-19 |
| PT101007B (pt) | 1999-07-30 |
| MX9206139A (es) | 1993-07-01 |
| GR3034135T3 (en) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| KR930007453A (ko) | 동결건조 이포스파미드 조성물 | |
| KR950703987A (ko) | G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf) | |
| DE69230610D1 (de) | Peptide mit zyklischen Hauptketten, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| SE8102194L (sv) | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna | |
| GR3006172T3 (da) | ||
| GB1446284A (en) | Neurotoxin | |
| SE8802569L (sv) | Foerbaettringar vid eller avseende somatosstatiner | |
| ATE159250T1 (de) | Neue pyrazinderivative, ihre herstellung und verwendung | |
| FI103408B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi | |
| ATE148165T1 (de) | Stabilisierung von hochgereinigten proteinen | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| DE69122364D1 (de) | Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen | |
| RU94038256A (ru) | Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе | |
| FI854926A0 (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler. | |
| DE3884680D1 (de) | Äusseres Membranprotein F von Pseudomonas aeruginosa. | |
| ES2145748T3 (es) | Composicion liofilizada que contiene s(+)-4,4'-(1-metil-1,2-etanodiil)-bis(2,6-piperazinodiona). | |
| MX9300205A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. | |
| WO1991015200A3 (en) | Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases | |
| DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
| JPS6416799A (en) | H-pth (1-34) composition and its preparation | |
| ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
| NO883520D0 (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
| Brittain et al. | Ultraviolet (UV) absorption and circular dichroism (CD) spectra of captopril | |
| DE69025859D1 (de) | Wasserfreie Kristalle von 4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-Olat |